A man on X is speaking out against Cigna Healthcare after the medical insurance company denied his late wife coverage for a ...

Pancreatic cancer is widely known as one of the most dangerous and difficult cancers to treat. Among the different types of pancreatic cancer, the most common and aggressive form is called pancreatic ...

A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with ...

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced ...

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

A UT Dallas and UT Southwestern study found tumors in younger patients develop in scar-like colon tissue — changes that may occur before cancer forms. Getty Images Last month, actor James Van Der Beek ...

For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only appeared on the inside of cells, where it sent signals that fueled tumor ...

Studies published by 20/20 Biolabs and several independent research groups in the U.S. and Asia over the past 10 months add to the growing body of evidence that our company’s patented multi-cancer ...

An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...

An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...

ctDNA MRD monitoring may augment scans and tumor markers, enabling earlier detection of gastroesophageal cancer recurrence, especially hard-to-image peritoneal relapse.